Clinics in Dermatology
Volume 27, Issue 3 , Pages 252-270 , May 2009

Rural dermatology in the tropics

  • Bernard Naafs, MD, PhD

      Affiliations

    • Institute for Dermatology and Venereology, Polderma Emmeloord/Steenwijk/Urk, Leiden University Medical Centre (LUMC), Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Gracht 15 8485KN, Munnekeburen, The Netherlands. Tel.: +31 561 481595; fax: +31 561 480757.
  • ,
  • Valeska Padovese, MD

      Affiliations

    • Mekele Civil Hospital, Mekele, Tigrea Province, Ethiopia

References 

  1. Etemesi E. Quality of life affected by skin diseases [thesis]. Tumaini University, Moshi, Tanzania. M Med Dermat 2001.
  2. Naafs B. The skin. In:  Parry E,  Godfrey R,  Mabey D,  Hill G editor. Principles of medicine in Africa. 3rd ed.. Cambridge, UK: Cambridge University Press; 2004;p. 1264–1301
  3. Van Hees C. Common skin diseases in Zimbabwe. In:  Van Hees C, Harare  editor. Zimbabwe; 2000;
  4. Grossmann H. Address to American Academy of Dermatology. Presented at the Annual Meeting of the American Academy of Dermatology, Miami, Florida, June 7-10. 1999;
  5. Kristense JK. Scabies and pyoderma in Lilonge Malawi. Prevalence and seasonal fluctuation. Int J Dermatol. 1991;30:699–702
  6. Canizaris O. Epidemiology and ecology of skin diseases in the tropics and the subtropics. In: A manual of dermatology for developing countries. New York, NY: Oxford University Press; 1982;p. 21–34
  7. Naafs B, Matemera BO, Mudarikwa L, Noto S. Position paper to Ministry of Health. 1986;Harare, Zimbabwe
  8. Doe PT, Asiedu A, Acheapong JW, Rowland Payne CM. Skin diseases in Ghana and the UK. Int J Dermatol. 2001;40:323–326
  9. Del Giudici P, Yves P. The widespread use of skin lightning creams in Senegal: a persistent public health problem in West Africa. Int J Dermatol. 2002;41:69–72
  10. Smeller W, Dzikus A. Skin diseases in children in rural Kenya: long term result of a dermatology project within the primary health care system. Br J Dermatol. 2001;144:118–124
  11. Moronne A. Poverty, health and development in dermatology. Int J Dermatol. 2007;46(suppl 2):1–9
  12. Hay RJ, Estrada Castanon R, Alarcon Hernandez H, et al. Wastage of family income on skin disease in Mexico. BMJ. 1994;309:848
  13. Figueroa JI, Fuller LC, Abraha A, Hay RJ. Dermatology in Southwestern Ethiopia: rational for a community approach. Int J Dermatol. 1998;377:52–58
  14. Gibbs S. Skin diseases and socioeconomic condition in rural Africa: Tanzania household dermatology. Int J Dermatol. 1996;35:633–639
  15. Satimia FT, McBride SR, Leppard B. Prevalence of skin disease in rural Tanzania and factors influencing the choice of health care, modern or traditional. Arch Dermatol. 1998;134:1363–1366
  16. Mayanja B, Margan D, Ross A, Whitworth J. The burden of mucocutaneous conditions and association with HIV-I infection in a rural community in Uganda. Trop Med Int Health. 1999;4:349–354
  17. Mahe A, Cisse IAH, Faye O, Diaye N, Niomba P. Skin diseases in Bamako (Mali). Int J Dermatol. 1998;37:673–676
  18. Shibeshi D. Pattern of skin diseases at the University teaching hospital Addis Ababa, Ethiopia. Int J Dermatol. 2000;39:822–825
  19. Mahé A. Bacterial skin infections in a tropical environment. Curr Opin Infect Dis. 2001;14:123–126
  20. Van Hees CLM, Naafs B. Common skin diseases in Africa. An illustrated guide. The Netherlands: Troderma Voorburg; 2001;
  21. Naafs B, Faber WR. Leprosy. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 89–101
  22. Zeegelaar JE. Ulcerating pyoderma. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 131–137
  23. Portaels F, Meyers WM. Buruli ulcer. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 117–129
  24. Adriaans B, Drasar BS. The isolation of fusobacteria from tropical ulcers. Epidemiol Infect. 1987;99:361–372
  25. Bulto T, Maskel FH, Fisseha G. Skin lesions in resettled and indigenous populations in Gambela with special emphasis on the epidemiology of tropical ulcer. Ethiop Med J. 1993;31:75–82
  26. Tumwine JK, Dungare PS, Tswana SA, Maoneke WR. Tropical ulcers in a remote area in Zimbabwe. Cent Afr J Med. 1989;35:413–416
  27. Engelkens HJH, Vuzevski VD, Stolz E. Nonvenereal treponematoses in tropical countries. Clin Dermatol. 1999;17:143–152
  28. Hay RJ. Fungal infections. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 89–103
  29. Shrum JP, Millikan LE, Batarneh O. Superficial fungal infection in the tropics. Dermatol Clin. 1994;12:687–693
  30. Savin R. Diagnosis and treatment of Tinea versicolor. J Fam Pract. 1996;43:127–132
  31. Bakker P, Van Doorne H, Gooskens V, Wieringa NF. Activity of gentian violet and brilliant green against some micro-organisms associated with skin infection. Int J Dermatol. 1992;31:210–213
  32. Nyst MJ, Perriens JH, Kimputu L, Lumbila M, Nelson AM, Piot P. Gentian violet, ketaconazole and nystatine in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Ann Soc Belg Med Trop. 1992;72:45–52
  33. Ayaya SO, Kumar KK, Kakar R. Aetiology of tinea capitis in school children. East Afr J. 2001;78:531–535
  34. Bergson CL, Fernandes NC. Tinea capitis: study of asymptomatic carriers and sick adolescents, adults and elderly who live with children with the disease. Rev Inst Med Trop Sao Paulo. 2001;43:87–91
  35. Develoux M. Griseofulvine. Ann Dermatol Venereol. 2001;128:1317–1325
  36. De Greef H, De Doncker P. Fighting fungal infections around the globe. Itraconazole in perspective. Kent, UK: Wells Medical Holdings Ltd; 2000;
  37. Gooskens V, Ponninghaus JM, Clayton Y, Mkandawire P, Sterne JA. Treatment of superficial mycosis in the tropics: Whitfield's ointment versus clotrimazole. Int J Dermatol. 1994;33:738–742
  38. Bergus GR, Johnson JS. Superficial tinea infection. Am Fam Physician. 1993;48:259–268
  39. Naafs B. Health aspects of second hand footwear: comments of a dermatologist. Memisa Medisch. 2001;67:88–89
  40. Tapia Collantes A. Dermatologia en el tropico. Rev Med Panama. 1995;20:65–71
  41. Hengge UR, Currie BJ, Jäger G, Lupi O, Schwartz RA. Scabies—a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6:769–779
  42. Chosidow O. Scabies and pediculosis. Lancet. 2000;355:819–822
  43. Jackson A, Heukelbach J, Filho AF, Júnior Ede B, Feldmeier H. Clinical features and associated morbidity of scabies in a rural community in Alagoas, Brazil. Trop Med Int Health. 2007;12:493–502
  44. Burkhart CN, Burkhart CG. Another look at ivermectin in the treatment of scabies and head lice. Int J Dermatol. 1999;38:235
  45. Burns DA. Myiasis. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 243–250
  46. Naafs B. Tropical holiday memories. Eur J Dermatol. 1999;6:499–505
  47. Heukelbach J, Feldmeier H. Creeping eruption (cutaneous larva migrans). In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 243–250
  48. Desjeux P. The increased risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239–243
  49. Vega Lopes F. Leishmaniasis: old world. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 193–208
  50. Silveira FT, Lainson R, Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Osw Cruz. 2004;99:239–251
  51. Talhari S, Chrusckiak Talhari C, de Oliveira Guerra JA. American cutaneous leishmaniasis. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 181–192
  52. Schipper HG, Kager PA. Fever and rash. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 139–159
  53. Naafs B. Allergic skin reactions in the tropics. Clin Dermatol. 2006;24:158–167
  54. Van Hees CLM, Kunkeler ACM, Naafs B. Cutaneous allergies in tropical countries. Expert Rev Dermatol. 2007;2:639–654
  55. Van den Biggelaar AH, Rodrigues LC, van Ree R, van der Zee JS, Hoeksma-Kruize YC, Souverijn JH, et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis. 2004;189:892–900
  56. Wördemann M, Diaz RJ, Heredia LM, et al. Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children. Trop Med Int Health. 2008;13:180–186
  57. Schmid-Grendelmeier P, Haug S. Beetle dermatitis. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 269–277
  58. Palangyo KJ. Cutaneous findings associated with HIV disease including AIDS: experiences from Sub-Saharan Africa. Trop Doctor. 1992;(Suppl 1):35–41
  59. Klostermann GF. Wie behandele ich die Eczema seborrhoicum. Z Hautkr. 1986;1561–1563
  60. Thami GK, Sakar R. Coal tar: past present and future. Clin Exp Dermatol. 2002;27:99–103
  61. Van Hees CLM. Persitent insect bites. In:  Faber WR,  Hay RJ,  Naafs B editor. Imported skin diseases. 1st ed.. Gezondheidszorg Maarssen, The Netherlands: Elsevier; 2006;p. 259–266
  62. Katta R. Lichen planus. Am Fam Physician. 2000;61:3319–3328
  63. Daramola OO, George AO, Ogunbigi AO. Hepatitis C and lichen planus in Nigerians: any relationship?. . Int J Dermatol. 2002;41:217–219
  64. Rebora A, Roberti E, Rongioletti F. Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci. 1994;4:38–41
  65. Price EW. Non-filarial elephantiasis—confirmed as a geochemical disease, and renamed podoconiosis. Ethiop Med J. 1988;26:151–153
  66. Narahari SR, Ryan TJ, Mahadevan PE, Bose KS, Prasanna KS. Integrated management of filarial lymphedema for rural communities. Lymphology. 2007;40:3–13
  67. Werth V. Current treatment of cutaneous lupus erythematosus. Dermatol Oline J. 2001;7:2
  68. Callen JP. Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol. 2002;16:245–264
  69. Naafs B, Bakkers EJ, Flinterman J, Faber WR. Thalidomide treatment of subacte cutaneous lupus erythematosus. Brit J Dermatol. 1982;107:83–86
  70. Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO, et al. Early undifferentiated connective tissue disease (CTD) VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Reumatol. 1999;26:816–825
  71. Venneker GT, Das PK, Naafs B, Tigges AJ, Bos JD, Asghar SS. Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endothelium. Br J Dermatol. 1994;131:237–242
  72. Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol. 2000;122:91–100
  73. Diaz LA, Sampaio SA, Rivitti EA, Martins CR, Cunha PR, Lombardi C, et al. Endemic pemphigus foliaceus (fogo selvagem): II. Current and historic epidemiologic studies. J Invest Dermatol. 1989;92:4–12
  74. Mahé A, Flageul B, Cissé I, Kéita S, Bobin P. Pemphigus in Mali: a study of 30 cases. Br J Dermatol. 1996;134:114–119
  75. Kallel Sellami M, Ben Ayed M, Mouquet H, et al. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus. Clin Exp Immunol. 2004;137:195–200
  76. Liu Z, Diaz LA. Bullous pemphigoid: end of the century overview. J Dermatol. 2001;28:647–650
  77. Khumalo NP, Murrell DF, Wojnarowska F, Kitschig G. A systemic review of treatments for bullous pemphigoid. Arch Dermatol. 2002;138:385–389
  78. Oranje AP, Vuzevski DV, Van Joost T, Ten Kate F, Naafs B. Bullous pemphigoid in children. Report of three cases with special emphasis on therapy. Int J Dermatol. 1991;30:39–42
  79. Hall RP. Dermatitis herpetiformis. J Invest Dermatol. 1992;99:873–881
  80. Leonard JN, Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol. 1991;9:403–408

PII: S0738-081X(08)00217-4

doi: 10.1016/j.clindermatol.2008.10.005

Clinics in Dermatology
Volume 27, Issue 3 , Pages 252-270 , May 2009